Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on LinkedIn for updates.
Optiq AI is integrated across three new imaging platforms: Artis genio, Artis icono.explore, and Artis icono.vision/Artis pheno.vision.

GERMANY— Siemens Healthineers from Germany is unveiling its latest imaging technology, Optiq AI, during this year’s Annual Meeting of the Radiological Society of North America (RSNA).
Powered by artificial intelligence, Optiq AI aims to produce higher-quality images with lower radiation doses, improving accuracy in image-guided medical procedures.
This innovative imaging system is compatible with three new platforms: Artis genio, Artis icono.explore, and Artis icono.vision/Artis pheno.vision.
As medical procedures grow increasingly complex, especially in treating delicate anatomies in early stages, there is a rising demand for precise imaging.
Minimally invasive treatments like transarterial embolizations require crystal-clear views of anatomical structures and medical devices.
However, challenges such as steep angulations in cardiac interventions or imaging obese patients often demand higher radiation doses, which can compromise image quality and patient safety.
Traditionally, clinicians face a trade-off between maintaining image clarity and minimizing radiation exposure to both patients and staff.
To address these issues, Siemens Healthineers developed Optiq AI, which integrates an AI-based algorithm into the image processing workflow.
This algorithm reduces noise caused by the imaging system’s electronics in real time, enhancing image clarity across various two-dimensional imaging modes.
These include fluoroscopy, image acquisition, and digital subtraction angiography, widely used in interventional radiology, cardiology, and minimally invasive surgeries.
Optiq AI also employs big data analytics during image acquisition to automatically select optimal imaging parameters tailored to the specific clinical needs.
The system dynamically adjusts settings such as tube voltage, tube current, copper prefiltration, focal spot size, pulse width, and detector dose.
It further accounts for factors like source-image distance and collimation.
When the imaging system moves or requires repositioning during a procedure, Optiq AI automatically recalibrates these parameters, maintaining image quality while keeping radiation doses as low as possible.
Carsten Bertram, head of Advanced Therapies at Siemens Healthineers, emphasized that the push for earlier and more precise treatments demands superior image quality, a goal now achievable through advanced artificial intelligence.
He noted that Optiq AI unleashes the potential of AI across new interventional systems, benefiting all clinical specialties by enhancing workflows and image clarity for better precision therapy.
Professor Samuel Tobias Sossalla, MD, director of cardiology at Kerckhoff Clinic Bad Nauheim and University Clinic Gießen, Germany, who has tested the new Artis genio and Artis icono.explore systems with Optiq AI for five months, described the technology as a significant breakthrough.
He stated that the AI-driven noise reduction produces remarkably sharp images of excellent quality, greatly aiding clinical work.
Optiq AI integrates with Siemens Healthineers’ most advanced interventional platforms.
Artis icono.vision and Artis pheno.vision target high precision and fast procedures, while Artis icono.explore focuses on high patient throughput with a powerful X-ray tube.
The versatile Artis genio platform balances productivity with flexibility to manage a wide range of cases.
This comprehensive portfolio ensures that healthcare providers can deliver safer, faster, and more precise image-guided therapies.
Be the first to leave a comment